Platelet inhibitors in the treatment of thrombosis.
D000328:Adult; D000368:Aged; D001166:Arteriovenous Shunt, Surgical; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy; D004176:Dipyridamole / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy; D011897:Random Allocation; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy*
D006886:Hydroxychloroquine; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone